HomeProductsBuilding BlocksHeterocyclic ScaffoldsAromatic HeterocyclesTenapanor
Chemical structure of CAS 1234423-95-0

Tenapanor

In Stock•Starting at $158 for 10 mg•Purity ≥ 96%
CAS No.1234423-95-0
MDL No.MFCD28386333
MFC50H66Cl4N8O10S2
MW1145.00
InChI KeyDNHPDWGIXIMXSA-CXNSMIOJSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
10 mg96%$158In Stock
25 mg96%$275In Stock
50 mg96%$459In Stock
100 mg96%$788In Stock
250 mg96%$1338In Stock
1 g96%$4274In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1234423-95-0
Product NameTenapanor

Biological Targets

SLC9A3

Associated Conditions

chronic kidney disease·hyperphosphatemia·constipation disorder·irritable bowel syndrome·Constipation
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Effect of Food Intake on the Pharmacodynamics of Tenapanor: A Phase 1 Study.

Clinical pharmacology in drug development • Vol. 6, Issue 5 • 2017
PMID: 28339149PMC: PMC5599956DOI: 10.1002/cpdd.341

Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug Interactions.

Clinical pharmacology in drug development • Vol. 6, Issue 5 • 2017
PMID: 28301096PMC: PMC5599994DOI: 10.1002/cpdd.346

Tenapanor hydrochloride for the treatment of constipation-predominant irritable bowel syndrome.

Expert opinion on investigational drugs • Vol. 24, Issue 8 • 2015
PMID: 26065434DOI: 10.1517/13543784.2015.1054480

Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.

Pharmacotherapy • Vol. 35, Issue 6 • 2015
PMID: 26016701DOI: 10.1002/phar.1594

Documentation

Similar Products